What is William Blair’s Estimate for NTLA Q2 Earnings?
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Equities researchers at William Blair issued their Q2 2026 EPS estimates for shares of Intellia Therapeutics in a research report issued on Wednesday, March 26th. William Blair analyst M. Minter expects that the company will post earnings of ($1.22) per share for the quarter. The consensus estimate […]
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Equities researchers at William Blair issued their Q2 2026 EPS estimates for shares of Intellia Therapeutics in a research report issued on Wednesday, March 26th. William Blair analyst M. Minter expects that the company will post earnings of ($1.22) per share for the quarter. The consensus estimate […]
